Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 59, p. e18893, 2023. DOI: 10.1590/s2175-97902020000118893. Disponível em: https://revistas.usp.br/bjps/article/view/212900.. Acesso em: 9 may. 2024.